With an ever increasing number of cell and gene therapies approaching commercialization, the key needs for the industry in terms of improved manufacturing equipment are threefold: GMP-ready equipment, process scalability and affordability.
Until now, the industry largely relied upon retrofitting existing equipment from the blood processing and biologics sectors to fit its needs. In order to truly see a step change in improved manufacturing it is crucial for tool providers to design equipment specifically for the GMP environment. Watch this On Demands webinar with Nina Bauer, Brian Dutra and Shirae Leslie of FloDesign Sonics as they reveal the latest data on the development of the most cutting edge of novel bioprocessing tools. During the webinar, they discuss: